Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Albendazole with fatty meal and dual-dosing for hookworm in Ugandan schoolchildren
PACTR202202738940158Not yet recruiting
- Sponsor
- World Vision Uganda
- Start
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of albendazole in hookworm infection and Soil-Transmitted Helminthiases (STH) (4 arms), sponsored by World Vision Uganda. Planned start Feb 2022; status: not yet recruiting.
02
Drugs
albendazole
03
Conditions
hookworm infectionSoil-Transmitted Helminthiases (STH)
Beyond the preview
Go deeper on PACTR202202738940158.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202202738940158.